Clinical Laboratory Improvement Advisory Committee: Notice of Charter Amendment, 43779 [2015-18065]

Download as PDF Federal Register / Vol. 80, No. 141 / Thursday, July 23, 2015 / Notices contracts awarded annually at $100,000 or more, of which 65 percent or 11,375 contracts will be competitively awarded. About 7 proposals will be received for each contract award. Of the total 79,625 (11,375 × 7) proposals received, only 25 percent or 19,906 proposals are expected to include uncompensated overtime hours. It is estimated that offerors will take about 30 minutes to identify and support any hours in excess of 40 hours per week included in their proposal or subcontractor’s proposal. Number of Respondents: 19,906. Responses Per Respondent: 1. Total Annual Responses: 19,906. Average Burden Hours Per Response: .5. Total Burden Hours: 9,953. C. Public Comments mstockstill on DSK4VPTVN1PROD with NOTICES Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the Federal Acquisition Regulation (FAR), and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW., Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000–0152, Service Contracting, in all correspondence. Dated: July 20, 2015. Edward Loeb, Acting Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2015–18077 Filed 7–22–15; 8:45 am] BILLING CODE 6820–EP–P VerDate Sep<11>2014 18:39 Jul 22, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Clinical Laboratory Improvement Advisory Committee: Notice of Charter Amendment This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Clinical Laboratory Improvement Advisory Committee, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS), has amended their charter to reduce the number of annual meetings and to change the designation of CDC, FDA and CMS from voting to non-voting ex officio members. The amended filing date is July 9, 2015. For information, contact Nancy Anderson, Chief, Laboratory Practice Standards Branch, Division of Laboratory Programs, Standards, and Services, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, CDC, 1600 Clifton Road, NE., Mailstop F–11, Atlanta, Georgia 30329– 4018; telephone (404) 498–2741. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–18065 Filed 7–22–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention 43779 portfolio review and the Pediatric mildTraumatic Injury Workgroup. There will be 15 minutes allotted for public comments at the end of the open session. On the second day, the BSC, NCIPC will meet to conduct a Secondary Peer Review of extramural research grant applications received in response to four (4) Funding Opportunity Announcements (FOAs): PHS 2014002 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR {R42/R44}); CE15–003, Evaluating Structural, Economic, Environmental, or Policy Primary Prevention Strategies for Intimate Partner Violence and Sexual Violence; CE15–004, Evaluating Innovative and Promising Strategies to Prevent Suicide among Middle-Aged Men; and CE15– 005, Research to Evaluate the CDC Heads Up Initiative in Youth Sports. Applications will be assessed as they relate to the Center’s mission and programmatic balance. Recommendations from the secondary review will be voted upon and the application will be forwarded to the Center Director for consideration for funding support. Contact Person For More Information: Arlene Greenspan, DrPH, MPH, PT, Associate Director for Science, Acting Designated Federal Officer, NCIPC, CDC, 4770 Buford Highway NE., Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–1279. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. 2015–18064 Filed 7–22–15; 8:45 am] BILLING CODE 4163–18–P Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) Correction: This notice was published in the Federal Register on June 16, 2015, Volume 80, Number 115, Page 34435. The Matters For Discussion and Contact Person For More Information should read as follows: Matters For Discussion: The BSC, NCIPC will discuss, research strategies needed to guide the Center’s focus, updates on the current research PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2015–N–2523] Intent To Review a Study Data Reviewer’s Guide Template AGENCY: Food and Drug Administration, HHS. E:\FR\FM\23JYN1.SGM 23JYN1

Agencies

[Federal Register Volume 80, Number 141 (Thursday, July 23, 2015)]
[Notices]
[Page 43779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-18065]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee: Notice of 
Charter Amendment

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Clinical Laboratory Improvement 
Advisory Committee, Centers for Disease Control and Prevention (CDC), 
Department of Health and Human Services (HHS), has amended their 
charter to reduce the number of annual meetings and to change the 
designation of CDC, FDA and CMS from voting to non-voting ex officio 
members. The amended filing date is July 9, 2015.
    For information, contact Nancy Anderson, Chief, Laboratory Practice 
Standards Branch, Division of Laboratory Programs, Standards, and 
Services, Center for Surveillance, Epidemiology and Laboratory 
Services, Office of Public Health Scientific Services, CDC, 1600 
Clifton Road, NE., Mailstop F-11, Atlanta, Georgia 30329-4018; 
telephone (404) 498-2741.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-18065 Filed 7-22-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.